WE-A-BRB-06: 3D In-Patient Dose Reconstruction from the PET-CT Imaging of Y-90 Microspheres for Metastatic Cancer to the Liver

2012 ◽  
Vol 39 (6Part25) ◽  
pp. 3932-3932 ◽  
Author(s):  
E Fourkal ◽  
I Veltchev ◽  
S Koren ◽  
M Lin ◽  
C Ma ◽  
...  
2013 ◽  
Vol 40 (8) ◽  
pp. 081702 ◽  
Author(s):  
E. Fourkal ◽  
I. Veltchev ◽  
M. Lin ◽  
S. Koren ◽  
J. Meyer ◽  
...  

2020 ◽  
Vol 1 (3) ◽  
Author(s):  
Anindita Rani Paul ◽  
Rajib Paul Chowdhury ◽  
Pritam Saha Podder ◽  
Umme Saoda

The leading cause of cancer-related death worldwide is lung cancer. While hematogenous spread from primary lung cancer to multiple other organs is frequently reported, metastases of malignant tumors to diaphragm and to spleen are rare. Nowadays, Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) has evolved in such a way that it has become a useful imaging modality in the assessment of various cancers, particularly for tumor staging and post treatment monitoring. It is able to provide metabolic information. In this case, we present an interesting integrated PET/CT imaging in a lung cancer patient with rare, diaphragm and splenic metastases. So, PET/CT could very well demonstrated rare and unexpected metastatic cancer and provided more accurate staging in a lung cancer patient.


2014 ◽  
Vol 41 (6Part14) ◽  
pp. 266-266
Author(s):  
I Veltchev ◽  
E Fourkal ◽  
M Doss ◽  
C Ma ◽  
J Meyer ◽  
...  

2005 ◽  
Vol 44 (S 01) ◽  
pp. S58-S60 ◽  
Author(s):  
W. Mohnike

Summary:PET is being considered a diagnostic commodity in clinical practice worldwide and thus receives increasing attention by health insurances and governmental organizations. In Germany, however, neither PET nor PET/CT are subject to reimbursement. This renders clinical PET and PET/CT imaging a challenge both in a general hospital environment and in private practice. This article describes briefly these challenges, which are not solely related to turf battles and associated costs.


2019 ◽  
Author(s):  
W van Boxtel ◽  
S Lütje ◽  
AC van Engen-van Grunsven ◽  
GW Verhaegh ◽  
JA Schalken ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2145-P
Author(s):  
ELIZABETH SANCHEZ RANGEL ◽  
JASON BINI ◽  
NABEEL B. NABULSI ◽  
YIYUN HUANG ◽  
KEVAN C. HEROLD ◽  
...  

2007 ◽  
Author(s):  
Stefan Krüger ◽  
S. Pauls ◽  
Felix M. Mottaghy ◽  
Andreas K. Buck ◽  
Hubert Schelzig ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document